Atlas Private Wealth Advisors Regeneron Pharmaceuticals, Inc. Transaction History

Atlas Private Wealth Advisors

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$692.45 - $844.37 $87,248 - $106,390	-126 Reduced 4.93%	2,432 $2 Million
Q2 2023 Aug 04, 2023	BUY	$700.03 - $830.35 $1.3 Million - $1.54 Million	1,850 Added 261.3%	2,558 $1.84 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $368,474 - $400,055	-522 Reduced 42.44%	708 $510,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $1,721 - $2,172	-3 Reduced 0.24%	1,230 $847,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $74,027 - $99,743	135 Added 12.3%	1,233 $729,000
Q4 2021 Apr 21, 2022	BUY	$543.48 - $670.97 $4,347 - $5,367	8 Added 0.73%	1,098 $693,000
Q3 2021 Oct 26, 2021	SELL	$574.03 - $680.96 $7,462 - $8,852	-13 Reduced 1.18%	1,090 $660,000
Q2 2021 Aug 02, 2021	BUY	$472.8 - $558.54 $2,836 - $3,351	6 Added 0.55%	1,103 $616,000
Q1 2021 Apr 28, 2021	BUY	$446.73 - $548.2 $8,934 - $10,964	20 Added 1.86%	1,097 $519,000
Q4 2020 Jan 29, 2021	BUY	$478.3 - $607.98 $510,824 - $649,322	1,068 Added 11866.67%	1,077 $520,000
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $4,439 - $5,795	9 New	9 $6,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Atlas Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Atlas Private Wealth Advisors with notifications on news.